August 19, 2017 3:20 PM ET


Company Overview of Ucyclyd Pharma, Inc.

Company Overview

Ucyclyd Pharma, Inc. provides life-saving medications for patients affected with urea cycle disorders (UCDs). It offers AMMONUL, a sodium phenylacetate and sodium benzoate injection for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. The company also provides BUPHENYL, the sodium phenylbutyrate tablets and powders for the chronic adjunctive management of hyperammonemia in patients with UCDs involving deficiencies of carbamyl phosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase. Ucyclyd Pharma sells its products through distributors in the United States, Canada, Sweden, Australia, ...

7720 North Dobson Road

Scottsdale, AZ 85256

United States

Founded in 1988





Key Executives for Ucyclyd Pharma, Inc.

Ucyclyd Pharma, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ucyclyd Pharma, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at